Cite
HARVARD Citation
Phillips, A. et al. (2018). Complete cytoreduction after five or more cycles of neo-adjuvant chemotherapy confers a survival benefit in advanced ovarian cancer. European journal of surgical oncology. 44 (6), pp. 760-765. [Online].